Aptus Pharma Limited (BOM:544529)

Market Cap	1.66B
Revenue (ttm)	291.80M +110.0%
Net Income	35.41M +1,358.7%
EPS	5.04 +51.6%
Shares Out	6.86M
PE Ratio	47.95
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	13,500
Open	227.75
Previous Close	232.35
Day's Range	227.75 - 236.95
52-Week Range	80.80 - 270.50
Beta	n/a
RSI	54.55
Earnings Date	Feb 10, 2026

About Aptus Pharma

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) fo...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2010
• Employees: 70
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544529

Financial Performance

In fiscal year 2025, Aptus Pharma's revenue was 245.58 million, an increase of 37.52% compared to the previous year's 178.57 million. Earnings were 31.00 million, an increase of 260.45%.